Consolidated Balance Sheet	Jul. 31, 2022 USD ($)
Current Assets
Cash	$ 718
Loan receivable	336,480
Total Current Assets	337,198
TOTAL ASSETS	337,198
Current Liabilities
Accounts payable and accrued liabilities	13,075
Deferred interest income	6,748
Due to related parties	8,812
Total Current Liabilities	28,635
TOTAL LIABILITIES	28,635
Stockholders' Equity
Series A preferred stock 100,000 designated; $0.001 par value 100,000 shares issued and outstanding	100
Common stock: 300,000,000 authorized; $0.001 par value 595,986 shares issued and outstanding	596
Additional paid in capital	331,105
Accumulated deficit	(23,238)
Total Stockholders' Equity	308,563
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 337,198

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.